Chemoinformaics analysis of 2’-glucosyl-4-hydroxyl-oxychalcone
| Molecular Weight | 402.399 | nRot | 6 |
| Heavy Atom Molecular Weight | 380.223 | nRig | 20 |
| Exact Molecular Weight | 402.131 | nRing | 3 |
| Solubility: LogS | -2.121 | nHRing | 1 |
| Solubility: LogP | 0.936 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 12 |
| nHA | 8 | APOL | 56.1554 |
| nHD | 5 | BPOL | 24.6746 |
| QED | 0.208 |
| Synth | 3.83 |
| Natural Product Likeliness | 1.362 |
| NR-PPAR-gamma | 0.018 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.018 |
| Pgp-sub | 0.442 |
| HIA | 0.808 |
| CACO-2 | -5.326 |
| MDCK | 0.00000651 |
| BBB | 0.297 |
| PPB | 0.977508 |
| VDSS | 0.902 |
| FU | 0.0186252 |
| CYP1A2-inh | 0.312 |
| CYP1A2-sub | 0.031 |
| CYP2c19-inh | 0.085 |
| CYP2c19-sub | 0.097 |
| CYP2c9-inh | 0.044 |
| CYP2c9-sub | 0.773 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.661 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.136 |
| CL | 2.472 |
| T12 | 0.604 |
| hERG | 0.246 |
| Ames | 0.894 |
| ROA | 0.301 |
| SkinSen | 0.8 |
| Carcinogencity | 0.613 |
| EI | 0.12 |
| Respiratory | 0.135 |
| NR-Aromatase | 0.88 |
| Antiviral | No |
| Prediction | 0.595168 |